Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
VersaBank completed a corporate reorganization to establish Versa Bancorp, a Delaware corporation, as its new U.S. bank holding company. Each outstanding common share of VersaBank was exchanged for one share of Versa Bancorp common stock, which will trade on Nasdaq and the TSX under the new ticker 'VRSA' starting around November 17, 2026.
Pasithea Therapeutics Corp. reported a net loss of $14.7 million for the nine months ended September 30, 2026, driven by a significant increase in research and development expenses to $11.1 million. The company maintained a cash position of $41.2 million as of the end of the period, down from $55.2 million at the start of the year.
For the nine months ended September 30, 2026, Health In Tech, Inc. reported total revenues of $23.4 million, a decrease from $25.8 million in the prior year period. The company experienced a significant shift in its financial position, moving from a retained earnings balance of $5.2 million at the end of 2025 to an accumulated deficit of $5.9 million as of September 30, 2026.
Flux Power Holdings received a deficiency notice from Nasdaq on November 9, 2026, for failing to maintain the minimum $2.5 million stockholders' equity requirement. The company has until December 24, 2026, to submit a plan to regain compliance and is also working to meet an extended December 4 deadline for a $4.0 million equity raise required by its lender, Gibraltar Business Capital.
Globalstar VP, Finance & Operations Timothy Evan Taylor Sells $11.2M of Stock
Timothy Evan Taylor, VP, Finance & Operations, sold 129,996 shares of Globalstar, Inc. at $86.16 to $86.38 a share (average $86.29) in 3 transactions, worth $11.2M in total between Nov 11, 2026 and Nov 12, 2026. Shares held after the trade: 80,244 (-52.9%).
Nuo Therapeutics reported a significant revenue increase to $4.9 million for the nine months ended September 30, 2026, compared to $2.2 million in the prior year, driven by product sales and distribution fees. Despite the growth, the company remains in a stockholders' deficit and continues to rely on debt financing, including $1.175 million in net proceeds from notes payable issued during 2026.
Douglas Elliman announced a major leadership transition including the retirement of CFO James B. Kirkland III and the departure of General Counsel Bradley H. Brodie. Heather Capriola, previously VP of Finance, has been appointed as the new Executive Vice President, Treasurer, and CFO. The departing executives will receive severance packages including cash payments and accelerated vesting of restricted shares.
Datavault AI received a delisting notice from Nasdaq due to non-compliance with the $1.00 minimum bid price requirement and a closing bid price below $0.10 for ten consecutive business days. Trading on Nasdaq will be suspended effective November 17, 2026, at which point the company expects its common stock to begin trading on the OTC Markets. The company intends to request a hearing before the Nasdaq Hearings Panel to present a compliance plan and seek an extension to maintain its listing.
Nuvve Holding Corp. reported a total revenue of $1.09 million for the quarter ended September 30, 2026, down from $1.60 million in the prior year period. The company experienced a net loss of $4.69 million for the quarter, contributing to a total stockholders' deficit of $13.42 million as of September 30, 2026.
Cheetah Net Supply Chain Service Financial Results
Cheetah Net Supply Chain Service reported Q3 2026 revenue of $3.56 million, an 883% increase year-over-year driven by its international trading business acquisition. Despite the revenue growth, the company reported a net loss from continuing operations of $2.55 million, primarily due to a $2.78 million non-cash loss from the change in fair value of acquisition-related contingent consideration.
Term
Q3 2026
“The third quarter of 2026 marked an important step forward in the execution of our business diversification strategy. Following the acquisition of Super International Trading Limited in May, our international trading business demonstrated encouraging momentum, generating approximately $3.56 million in revenue during the quarter.”
Tony Liu, Cheetah’s Chairman and CEO
“Looking ahead, we remain committed to disciplined capital allocation, prudent financial management, and the pursuit of strategic opportunities that complement our existing capabilities.”
Azio AI Holdings held its 2026 Annual Meeting where stockholders approved the 2026 Equity Incentive Plan and several other proposals. The meeting was adjourned until December 4, 2026, specifically to address Proposal 4 regarding the issuance of common stock upon conversion of Series A Preferred Stock, pending Nasdaq listing application approval. Approximately 54.2% of outstanding shares were represented at the meeting, constituting a quorum.
CaliberCos Inc. reported a net loss of $18.0 million for the nine months ended September 30, 2026, compared to a $15.0 million loss in the prior year period. Total assets increased significantly to $178.9 million from $135.4 million at year-end 2025, primarily driven by the consolidation of new investment funds and real estate assets.
AiRWA Inc. entered into securities purchase agreements with certain investors to sell 1,800,000 shares of common stock at $0.8332 per share. The transaction is expected to generate gross proceeds of approximately $1.5 million for working capital and general corporate purposes. The offering was conducted as a private placement in reliance on Section 4(a)(2) and Regulation D.
Cumberland Pharmaceuticals reported a significant net income of $77.8 million for the quarter ended September 30, 2026, primarily driven by an $81.1 million gain from the disposal of discontinued operations. Total revenue from continuing operations increased to $2.2 million, while the company declared a substantial cash dividend of $22.5 million during the period.
Arora Ashish, CEO, sold 210,000 shares of Cricut, Inc. at $8.58 to $8.95 a share (average $8.72) in 3 transactions, worth $1.83M in total between Nov 11, 2026 and Nov 13, 2026. Shares held after the trade: 4,698,740 (-1.5%).
Where Food Comes From reported Q3 2026 total revenue of $7.3M, up 4% year-over-year, driven by 6% growth in its core verification and certification business. Operating income grew 68% to $1.0M as gross margins expanded to 42.1% due to cost-reduction initiatives and service bundling. The company also returned $268,000 to shareholders through stock buybacks during the quarter.
Term
Q3 2026
“We are pleased to report strong third quarter financial results highlighted by 6% growth in our core verification and certification business that is benefitting from resurgent demand for beef-related services and growing momentum in other service offerings.”
John Saunders, Chairman and CEO
“Our profit metrics also showed continued strength with gross margins rising by 380 basis points to 42.1% and operating income growing 68% to $1.0 million from $600,000 a year ago – both reflecting the positive impact of our ongoing cost down initiatives in conjunction with accelerating revenue.”
Research Alliance Corp IV reported a net income of $379,042 for the quarter ended September 30, 2026, primarily driven by $534,815 in interest earned on marketable securities held in the Trust Account. As a shell company, its activities are focused on identifying a target for a business combination, with $75,534,815 currently held in trust for its Class A ordinary shares.
CIM Opportunity Zone Fund, L.P. reported a net loss of $44.8 million for the nine months ended September 30, 2026, compared to a net income of $110.8 million in the prior year period. The decline was primarily driven by the absence of a $117.4 million realized gain on a lease investment recorded in 2025 and increased operating and interest expenses.
Korro Bio Director Jean Francois Formela Sells $964K of Stock
Jean Francois Formela, Director, sold 66,015 shares of Korro Bio, Inc. at $14.30 to $15.60 a share (average $14.60) in 5 transactions, worth $964K in total between Nov 11, 2026 and Nov 12, 2026. Shares held after the trade: 121,219 (-5.4%).
DataMeds AI, Inc. (formerly Wellgistics Health, Inc.) reported a net income of $10.5 million for the quarter ended September 30, 2026, primarily driven by a $19.1 million gain on debt extinguishment. However, the company experienced a significant decline in nine-month revenues from $21.7 million in 2025 to $6.0 million in 2026, resulting in a year-to-date net loss of $15.6 million.
Booking Holdings Debt Financing Update with U.S. Bank Trust Company, National Association
Booking Holdings Inc. entered into an indenture for the sale of €1.25 billion in aggregate principal amount of senior notes. The transaction was executed via four Officers' Certificates under a base indenture with U.S. Bank Trust Company as trustee. The filing discloses the creation of a direct financial obligation related to these senior notes.
GRI Bio, Inc. reported a net loss of $5.15 million for the nine months ended September 30, 2026, a significant reduction from the $9.30 million loss in the prior year period, primarily due to lower research and development expenses. The company strengthened its liquidity through an ATM offering, ending the period with $9.47 million in cash and cash equivalents. GRI Bio remains a clinical-stage biopharmaceutical company with an accumulated deficit of $56.84 million and no significant revenue.
Processa Pharmaceuticals reported a significant net loss of $189.8 million for the nine months ended September 30, 2026, primarily driven by a $178.0 million charge for acquired in-process research and development following the acquisition of Vidya Therapeutics. The company significantly strengthened its liquidity position during the period, ending with $180.2 million in cash and cash equivalents following a $200.0 million private placement financing.
Valor Energy Inc reported a significant net loss of $40.8 million for the six months ended September 30, 2026, primarily driven by a $34.1 million non-cash charge for the excess of warrant fair value over offering proceeds. Despite the loss, the company strengthened its cash position to $12.5 million following a $10.2 million net inflow from a Units Private Placement.
Venture Global Senior VP, Development Fory Musser Sells $6.58M of Stock
Fory Musser, Senior VP, Development, sold 500,000 shares of Venture Global, Inc. at $13.16 a share, worth $6.58M in total on Nov 12, 2026. Shares held after the trade: 0 (-100.0%).
Health In Tech, Inc. has prepared a formal investor presentation deck to be used by management at upcoming conferences and meetings. The presentation highlights the company's AI-powered marketplace platform designed to help small- and medium-sized businesses access self-funded health plans. The filing includes the full slide deck as Exhibit 99.1 for investor review.
Monolithic Power Systems CFO Frank Anthony Balow III Sells $28.7K of Stock
Frank Anthony Balow III, CFO, sold 20 shares of Monolithic Power Systems, Inc. at $1,434.31 a share, worth $28.7K in total on Nov 11, 2026. Shares held after the trade: 2,921 (-0.7%).
Astrotech reported a net loss of $2.9 million for the quarter ended September 30, 2026, compared to a $3.5 million loss in the prior year. Revenue decreased slightly to $274 thousand, while the company maintained a cash position of $5.6 million following an 'at-the-market' share issuance that raised $467 thousand.
Health In Tech, Inc. announced a leadership transition separating the roles of Executive Chairman and Chief Executive Officer. Founder Tim Johnson will serve as Executive Chairman focusing on long-term strategy and innovation, while Sanjay Shrestha has been appointed as the new CEO to lead day-to-day operations and commercial execution.
Kairos Pharma, Ltd. reported a net loss of $5.03 million for the nine months ended September 30, 2026, compared to a $4.08 million loss in the prior year period. The company remains in the development stage with no revenue, and its cash position decreased to $3.13 million as of September 30, 2026, from $4.49 million at year-end 2025.